ALBANY, N.Y., Jan. 6, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on Thursday, January 12, 2012, at 10:30 a.m. Pacific Time. Joseph M. DeVivo, President and Chief Executive Officer of AngioDynamics, will review the Company’s business strategy and recent corporate developments.
